Fibroblast Growth Factor 7: all 43 studies that test it

Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.

• Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIMEnrolling by invitationNCT07775313Phase 1/2
• Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refractory Crohn DiseaseNot yet recruitingNCT06986382Phase 1/2
• Base Editing Hematopoietic Stem Cell and T Cell Gene Therapy for CD40L-HyperIgM Syndrome: Single Patient StudyRecruitingNCT06959771Phase 1/2
• Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene TherapyEnrolling by invitationNCT06851767Phase 1/2
• Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous DiseaseRecruitingNCT06325709Phase 1/2
• Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)RecruitingNCT01306019Phase 1/2
• Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell TransplantationCompletedNCT02356159Phase 1/2Results posted
• Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal NecrolysisTerminatedNCT02037347Phase 1/2Results posted
• Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic CancerCompletedNCT01233921Not applicableResults posted
• Study to Characterize the Effect of Heparin on Palifermin ActivityCompletedNCT01163097Phase 1Results posted
• Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)CompletedNCT00629798Phase 2Results posted
• A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent ChemotherapyCompletedNCT00626639Phase 1/2Results posted
• Phase 2 Haplotype Mismatched HSCT in Patients With Hematological MalignanciesTerminatedNCT00593554Phase 2Results posted
• A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCTCompletedNCT00460421Phase 1Results posted
• A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple MyelomaCompletedNCT00434161Phase 3Results posted
• Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected AdultsCompletedNCT00376935Phase 2Results posted
• Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck CancerTerminatedNCT00360971Phase 3Results posted
• Evaluate PKs and Efficacy Assessment of Palifermin in Patients With SarcomaCompletedNCT00267046Phase 2Results posted
• Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) TransplantationCompletedNCT00189488Phase 2Results posted
• Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)CompletedNCT00109031Phase 3Results posted
• Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck CancerCompletedNCT00101582Phase 3Results posted
• Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00094861Phase 2Results posted
• Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced AlopeciaCompletedNCT04554732Early Phase 1
• Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined ImmunodeficiencyStatus unknownNCT03315078Phase 1/2
• A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid TumorsTerminatedNCT02653196Early Phase 1
• Palifermin for Patients Receiving Hematopoietic Stem Cell TransplantationStatus unknownNCT02313792Phase 3
• Keratinocyte Growth Factor to Prevent Autoimmunity After Alemtuzumab Treatment of Multiple SclerosisTerminatedNCT01712945Phase 1/2
• A Study to Assess Safety and Efficacy of a Novel Treatment, Keratinocyte Growth Factor (KGF), in Asthmatic PatientsCompletedNCT01386151Phase 2
• Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT01085617
• Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)TerminatedNCT00881556Early Phase 1
• Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell TransplantWithdrawnNCT00728585Phase 2
• Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell TransplantationCompletedNCT00701688Phase 1
• Palifermin After Haploidentical PBSCTWithdrawnNCT00570999Phase 2
• A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative RadiotherapyWithdrawnNCT00540332Phase 1/2
• Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple MyelomaCompletedNCT00482846Phase 1
• A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon CancerCompletedNCT00393822Phase 2/3
• Palifermin DDI (Drug Drug Interaction)CompletedNCT00361348Phase 1
• PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC TransplantationCompletedNCT00352703Phase 4
• A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck CancerCompletedNCT00131638Phase 3
• Recombinant Human Keratinocyte Growth Factor in Unrelated and Related TransplantsCompletedNCT00056875Phase 1/2
• Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose ChemotherapyCompletedNCT00041665Phase 3
• Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHDTerminatedNCT00038792Phase 1/2
• Keratinocyte Growth Factor to Prevent Acute GVHDCompletedNCT00031148Phase 1/2

← Fibroblast Growth Factor 7 overview